STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

TSHA

Taysha Gene Therapies, Inc.
CIK 0001806310 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
21.6
composite ยท 3 signals ยท CLEAN

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-13 ยท FY 2023-12-31 ยท ELEVATED100.0

Zombie / distress

[FY2023 data, stale โ€” no more recent EBIT figure in XBRL] Interest coverage -14.49x below 1.0
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2025-02-26) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2025-12-31": null,
    "2024-12-31": null,
    "2023-12-31": -14.494,
    "2022-12-31": -42.772
  },
  "consecutive_years_below_1": 2,
  "altman_z_double_prime": -7.4,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -72439000,
    "interest_expense_t": 4998000
  },
  "stale": true,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1806310/000095017025027348/0000950170-25-027348-index.htm",
    "form": "10-K",
    "filed": "2025-02-26"
  }
}
P-01 ยท FY 2025-12-31 ยท CLEAN26.3

Earnings quality

Beneish M-Score -2.58 โ€” no manipulation profile
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2026-03-19) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": -2.579,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1,
    "GMI": 1,
    "AQI": 0.519,
    "SGI": 1.173,
    "DEPI": 0.982,
    "SGAI": 1,
    "LVGI": 0.51,
    "TATA": -0.046
  },
  "defaulted_to_neutral": [
    "DSRI",
    "GMI",
    "SGAI"
  ],
  "sloan_accruals": -0.0632,
  "inputs": {
    "revenue_t": 9773000,
    "revenue_t1": 8333000,
    "total_assets_t": 343320000,
    "net_income_t": -108995000,
    "cfo_t": -93090000
  },
  "stale": false,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1806310/000119312526115202/0001193125-26-115202-index.htm",
    "form": "10-K",
    "filed": "2026-03-19"
  }
}
P-12 ยท FY 2025-12-31 ยท CLEAN2.9

Restatement predictor

F-Score 0.09 โ€” at or below the population base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2026-03-19) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 0.087,
  "probability": 0.00032,
  "components": {
    "rsst": -0.0632,
    "drec": null,
    "dinv": null,
    "soft": 0.049,
    "dcs": 0.1728,
    "droa": 0.2394,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2025-12-31",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1806310/000119312526115202/0001193125-26-115202-index.htm",
    "form": "10-K",
    "filed": "2026-03-19"
  }
}